Craft

Nippon Chemiphar

Stock Price

¥1.5 K

2024-10-29

Market Capitalization

¥5.3 B

2024-10-29

Revenue

¥32.6 B

FY, 2025

Nippon Chemiphar Summary

Company Summary

Overview
Nippon Chemiphar is a pharmaceutical company that specializes in the development of generic drugs. It is also engaged in the production of clinical laboratory equipment and reagents as well as various healthcare products, including nutrients, health foods, cosmetics, and more. The company focuses on hyperuricemia, pain management, metabolism, and other therapeutic areas.
Type
Public
Status
Active
Founded
1950
HQ
Chiyoda City, JP | view all locations
Website
https://www.chemiphar.co.jp/
Cybersecurity rating
Sectors

LocationsView all

6 locations detected

  • Chiyoda City, Tokyo HQ

    Japan

    2-chōme-2-3 Iwamotochō

  • Fukuoka, Fukuoka

    Japan

    2-chōme-10-35 Hakataekihigashi, Hakata Ward

  • Osaka, Osaka

    Japan

    2-chōme-3-2 Utsubohonmachi, Nishi Ward

  • Saitama, Saitama

    Japan

    Miyahara Station, 3-chōme Miyaharachō, Kita Ward

  • Sapporo, Hokkaido

    Japan

  • Sendai, Miyagi

    Japan

    Kakyoin Square, 18th Floor, 1-chōme-1-20 Kakyōin, Aoba Ward

Nippon Chemiphar Financials

Summary Financials

Revenue (H1, 2026)
¥15.9B
Gross profit (H1, 2026)
¥4.9B
Net income (H1, 2026)
¥163.0M
Cash (H1, 2026)
¥9.0B
EBIT (H1, 2026)
¥178.0M
Enterprise value
$14.6B

Footer menu